Imricor Medical Systems
(ASX) IMR
Imricor Medical Systems Financials at a Glance
Market Cap
A$561.66M
Revenue (TTM)
$1.16M
Net Income (TTM)
-$48.66M
EPS (TTM)
-A$0.13
P/E Ratio
-13.70
Dividend
A$0.00
Beta (Volatility)
-0.01 (Low)
Dividend
A$0.00
Beta (Volatility)
-0.01 (Low)
Price
A$1.75
Volume
470,998
Open
A$1.68
Price
A$1.75
Volume
470,998
Open
A$1.68
Previous Close
A$1.75
Daily Range
A$1.64 - A$1.75
52-Week Range
A$1.15 - A$2.25
Estimated Earnings Date
Sep 1, 2026
Dividend
A$0.00
Beta (Volatility)
-0.01 (Low)
Price
A$1.75
Volume
470,998
Open
A$1.68
Previous Close
A$1.75
Daily Range
A$1.64 - A$1.75
52-Week Range
A$1.15 - A$2.25
Estimated Earnings Date
Sep 1, 2026
IMR News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Imricor Medical Systems
Industry
Healthcare Equipment and Supplies
Sector
Health CareCEO
Steven Wedan
Website
www.imricor.comHeadquarters
Burnsville, MN 55337, US
IMR Financials
Key Financial Metrics (TTM)
Gross Margin
-9%
Operating Margin
-89%
Net Income Margin
-97%
Return on Equity
-1465%
Return on Capital
-61%
Return on Assets
-41%
Earnings Yield
-7.30%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
A$561.66M
Shares Outstanding
320.95M
Volume
471.00K
Avg. Volume
379.34K
Financials (TTM)
Gross Profit
-$2.10M
Operating Income
-$23.59M
EBITDA
-$22.56M
Operating Cash Flow
-$19.75M
Capital Expenditure
-$449.43K
Free Cash Flow
-$20.20M
Cash & ST Invst.
$40.81M
Total Debt
$26.62M
Imricor Medical Systems Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$97.19K
-76.7%
Gross Profit
-$1.44M
-287.0%
Gross Margin
-14.87%
N/A
Market Cap
A$561.66M
N/A
Market Cap/Employee
A$7.20M
N/A
Employees
78
N/A
Net Income
-$12.40M
+7.5%
EBITDA
-$11.34M
-53.7%
Quarterly Fundamentals
Total Cash
$40.81M
+4807.6%
Total Debt
$26.62M
+155.4%
Accounts Receivable
$241.03K
-38.6%
Inventory
$1.10M
-34.8%
Long Term Debt
$14.55M
+49.1%
Short Term Debt
$12.07M
+1707.2%
Return on Assets
-41.43%
N/A
Return on Invested Capital
-61.43%
N/A
Free Cash Flow
-$10.03M
-48.0%
Operating Cash Flow
-$9.84M
-45.2%